SAKAMURI; Sukumar

Patent Applications and Registrations

Patent applications and USPTO patent grants for SAKAMURI; Sukumar.The latest application filed is for "compositions containing, methods and uses of antibody-tlr agonist conjugates".

Company Profile

5.4.19

SAKAMURI; Sukumar - La Jolla CA
Sakamuri; Sukumar - San Diego CA
Sakamuri; Sukumar - Indira Nagar IN
Sakamuri, Sukumar - Plainsboro NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions Containing, Methods And Uses Of Antibody-tlr Agonist Conjugates App 20220226488 - MOON; Sung-Ju ; et al.	2022-07-21
Immunomodulating Polynucleotides, Antibody Conjugates Thereof, And Methods Of Their Use App 20220056069 - Sakamuri; Sukumar ; et al.	2022-02-24
Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use Grant 11,203,611 - Sakamuri , et al. December 21, 2	2021-12-21
Polynucleotide Constructs Having Bioreversible And Non-bioreversible Groups App 20200392498 - BRADSHAW; Curt W. ; et al.	2020-12-17
Chiral Phosphoramidite Auxiliaries And Methods Of Their Use App 20200140476 - SAKAMURI; Sukumar ; et al.	2020-05-07
Polynucleotide Constructs App 20190202855 - SAKAMURI; Sukumar ; et al.	2019-07-04
Polynucleotide Constructs Having An Auxiliary Moiety Non-bioreversibly Linked To An Internucleoside Phosphate Or Phosphorothioat App 20190194655 - BRADSHAW; Curt W. ; et al.	2019-06-27
Mononucleotides Having A Bioreversible Disulfide Group App 20180346505 - BRADSHAW; Curt W. ; et al.	2018-12-06
Immunomodulating Polynucleotides, Antibody Conjugates Thereof, And Methods Of Their Use App 20180312536 - Sakamuri; Sukumar ; et al.	2018-11-01
Polynucleotide Constructs Having Bioreversible And Non-bioreversible Groups App 20170114341 - BRADSHAW; Curt W. ; et al.	2017-04-27
Polynucleotide Constructs Having Disulfide Groups App 20160257961 - BRADSHAW; Curt W. ; et al.	2016-09-08
Dipeptidyl peptidase IV inhibitors Grant 8,466,145 - Balasubramanian , et al. June 18, 2	2013-06-18
Dipeptidyl Peptidase Iv Inhibitors App 20110257164 - Balasubramanian; Gopalan ; et al.	2011-10-20
Tubulysin analogues Grant 7,816,377 - Domling , et al. October 19, 2	2010-10-19
Glucagon-like Protein-1 Receptor (glp-1r) Agonist Compounds App 20090098130 - BRADSHAW; Curt W. ; et al.	2009-04-16
Novel tubulysin analogues App 20050239713 - Domling, Alexander ; et al.	2005-10-27
Novel anticancer compounds App 20050228017 - Menon, Sanjay R ; et al.	2005-10-13
2-3-disubstituted quinuclidiness as modulators of monoamine transporters and theraperutic and diagnostic methods based thereon App 20050131051 - Wang, Shaomeng ; et al.	2005-06-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.